PubMed
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Sikiric et al., 2018
GLOW Stack · GHK-Cu + BPC-157
GLOW is a community / supplier name for a pre-blended vial that typically combines GHK-Cu with BPC-157 (some catalogs also include TB-500 — see Glow 70 variants). PeptIQ tracks GLOW as an educational blend so single-vial products can be searched and logged without inventing separate medical claims for the mixture. Evidence for each ingredient lives on the component pages; the blend itself is not FDA-approved.
Overall check-ins
Trackers & reports
Overview
GLOW is a community / supplier name for a pre-blended vial that typically combines GHK-Cu with BPC-157 (some catalogs also include TB-500 — see Glow 70 variants). PeptIQ tracks GLOW as an educational blend so single-vial products can be searched and logged without inventing separate medical claims for the mixture. Evidence for each ingredient lives on the component pages; the blend itself is not FDA-approved.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 45% · Mixed 38% · Unfavorable overall 17%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 50–1000 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 55% said they felt similar to their last entry, 43% more positive, and 15% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 32 days · Based on 282 repeat reporters
Community charts use modeled aggregates when live Supabase snapshots are unavailable.
Research
PubMed
Sikiric et al., 2018
Review Article
Pickart et al., 2018
Tools
More ways to learn about GLOW Blend from observational PeptIQ data.
Compare with
Related peptides
Help
This page summarizes 1,281 anonymized self-reports from PeptIQ users who track GLOW Blend, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. GLOW Blend is listed as Research Only. Consult a licensed clinician for personal medical decisions.
This wiki summarizes observational community reports and linked citations for GLOW Blend. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for GLOW Blend for study-level context — not medical advice.
GLOW Blend is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
Safety data quality for GLOW Blend varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
This page links 2 indexed sources for GLOW Blend. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.